UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001142 |
|---|---|
| Receipt number | R000001386 |
| Scientific Title | Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia. |
| Date of disclosure of the study information | 2008/05/10 |
| Last modified on | 2011/10/31 16:03:29 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/04/30 19:07:32 | ||
| 2 | Update | 2009/10/30 15:48:03 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 3 | Update | 2010/05/14 18:26:02 | Date analysis concluded |
|
| 4 | Update | 2011/10/31 16:03:29 | Recruitment status Date analysis concluded Publication of results URL related to results and publications Results Results |
